Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H14N6O |
InChIKeyTVLLDLQHOTXTRV-UHFFFAOYSA-N |
CAS Registry477726-81-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 01 Nov 2003 |